PACB — Pacific Biosciences of California Share News
0.000.00%
- $609.23m
- $1.02bn
- $160.01m
U.S. STOCKS ON THE MOVE-Walmart, Ford Motor, Starbucks
U.S. STOCKS ON THE MOVE-Simply Good Foods, Microbot Medical, PacBio
PacBio to cut jobs, lower spending over NIH funding cuts and tariffs
PacBio rises on strong preliminary Q1 revenue, layoff plan
Brief: Pacbio posts Preliminary Q1 2025 Revenue And Reiterates 2025 Revenue Guidance
Brief: Jim Gibson To Join PacBio As Chief Financial Officer
U.S. STOCKS ON THE MOVE-Meta Platforms, Dexcom, Dell
U.S. STOCKS ON THE MOVE- Analog Devices, GameStop, Moderna
Pacific Biosciences falls on Q4 revenue miss
Pacific Biosciences of California Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Pacific Biosciences of California Q4 Adjusted Net Income USD -55.3 Million Vs. IBES Estimate USD -60.6 Million
Pacific Biosciences of California Inc expected to post a loss of 21 cents a share - Earnings Preview
Brief: PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service
Pacific Biosciences of California Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Pacific Biosciences of California Q3 Adjusted EPS USD -0.17 Vs. IBES Estimate USD -0.22
Bernstein expects a 'not so scary' Q3 for US life sciences firms
Pacific Biosciences of California Inc reports results for the quarter ended in June - Earnings Summary
Brief: Pacific Biosciences of California Q2 Revenue USD 36 Million Vs. IBES Estimate USD 40.9 Million
Pacific Biosciences of California Inc expected to post a loss of 23 cents a share - Earnings Preview